Jackson Free Press

Dr. Lucio Miele of University of Mississippi Medical Center is the newest member of the American Cancer Society's Mid-South Division Board of Directors.

A native of Naples, Italy, Miele previously served as a volunteer with the American Cancer Society, including research. He also served on the organization's Physicians Advisory Council. 
 
Miele, director of the UMMC Cancer Institute and Ergon Professor of Medicine and Pharmacology at UMMC, serves as chair of the Cancer Institute Executive Committee at UMMC and as co-chair of the National Cancer Institute's task force on cancer stem cells. He serves on a number of cancer-research grant review panels for the National Cancer Institute, National Institutes of Health and the Department of Defense. He also serves on grant review panels for cancer research agencies from the United Kingdom, Canada, the Netherlands, Italy and India.
 
The doctor attended European universities, including the Max Planck Institute in Germany. Miele completed his medical degree in 1982 summa cum laude and his doctorate in biochemistry in 1988 summa cum laude from the University of Naples, Italy, where he was a biochemistry instructor. He served as a visiting fellow, an adjunct scientist and a visiting associate in the Human Genetics Branch of the National Institute of Child Health and Human Development, National Institutes of Health. He joined the U.S. Food and Drug Administration in 1994 as a tenure-track principal investigator in the Laboratory of Cell Biology, Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research and served the organization as acting chief of the laboratory from March 1997-May 1998.
 
In May 1998, Miele joined the Loyola University Medical Center, Chicago, as an assistant professor in the Department of Pathology, Cardinal Bernardin Cancer Center, and director of DNA Sequencing and Recombinant DNA Laboratory and Proteomics Laboratory, Molecular Pathology Research Facility, Department of Pathology. He became an associate professor of pharmacology at the University of Illinois at Chicago in August 2001, and became director of the Molecular Pathogenesis and Signaling Program at the UIC Cancer Center in 2003. He returned to Loyola in 2005 as professor of pathology and pharmacology and director of the Breast Cancer Research Program at the Bernardin Cancer Center. He became associate director for translational science at the Bernardin Cancer Center in 2007.
 
Miele has served in a number of administrative and scientific leadership positions, including director of the Cell Signaling Program at the UIC Cancer Center and associate director for translational science at the Bernardin Cancer Center. Widely published in peer-reviewed publications, Miele has served as a referee for many journals and granting agencies. He serves as an assistant editor of the Women's Oncology Reviews, associate editor of the Journal of Cellular Biochemistry and Current Molecular Medicine, and executive editor of the Americas for the Journal of Experimental Clinical Cancer Research.
 
The American Cancer Society's Mid-South Division includes Alabama, Arkansas, Kentucky, Louisiana, Mississippi and Tennessee, as well as Clark and Floyd counties, Indiana.
 
For information, contact the American Cancer Society at 800-227-2345 or visit cancer.org. For information about the UMMC Cancer Institute, visit umhc.com.